The rare disease drug developer is turning to former Genentech head Alexander Hardy as the launch of its Roctavian gene therapy stumbles.
News Ticker
- [ December 3, 2023 ] IDEAYA Announces Agenda for Investor R&D Day Webcast on December 4, 2023 News
- [ December 2, 2023 ] Staff Architect, User Experience – Thermo Fisher Scientific – Fremont, CA San Francisco Biotech Jobs
- [ December 2, 2023 ] FDA’s CAR-T safety probe; AbbVie’s $10B ADC wager; Pfizer’s GLP-1 setback; Acelyrin’s CRO drama; and more News
- [ December 2, 2023 ] Life Science Lab Assistant – Cardiovascular Diseases – PAVIR – Palo Alto, CA San Francisco Biotech Jobs
- [ December 2, 2023 ] Research Associate – CLINICAL FORMULATION – CELL THERAPY – Novo Nordisk – Fremont, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
